Uwe Trefzer Selected Research

Uwe Trefzer Research Topics

Disease

53	Melanoma (Melanoma, Malignant) 09/2019 - 08/2003
22	Neoplasms (Cancer) 09/2019 - 09/2003
11	Neoplasm Metastasis (Metastasis) 01/2014 - 01/2005
4	Disease Progression 09/2013 - 03/2006
3	Basal Cell Carcinoma (Rodent Ulcer) 07/2016 - 06/2008
3	Diarrhea 02/2013 - 06/2009
3	Exanthema (Rash) 02/2013 - 07/2012
3	Brain Neoplasms (Brain Tumor) 11/2012 - 01/2006
2	Pruritus (Itching) 01/2014 - 02/2013
2	Neutropenia 11/2012 - 10/2006
2	Merkel Cell Carcinoma 02/2010 - 05/2006
2	Thrombocytopenia (Thrombopenia) 06/2009 - 10/2006
2	Testicular Neoplasms (Testicular Cancer) 05/2008 - 04/2006
1	Body Weight (Weight, Body) 09/2013
1	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 03/2013
1	Seizures (Absence Seizure) 03/2013
1	Cerebellar Ataxia (Dysmetria) 03/2013
1	Eosinophilia 01/2013
1	Aseptic Meningitis 01/2013
1	Inflammation (Inflammations) 01/2013
1	Edema (Dropsy) 07/2012
1	Ovarian Neoplasms (Ovarian Cancer) 05/2012
1	Lymphatic Metastasis 09/2011
1	Fatigue 06/2009

Drug/Important Bio-Agent (IBA)

9	Dacarbazine (DIC)FDA LinkGeneric 09/2019 - 01/2005
6	AntigensIBA 01/2009 - 09/2003
5	Proteins (Proteins, Gene)FDA Link 09/2019 - 06/2006
5	Monoclonal AntibodiesIBA 01/2014 - 10/2005
5	AntibodiesIBA 03/2013 - 05/2005
4	LigandsIBA 02/2014 - 06/2006
4	ParaffinIBA 01/2014 - 10/2005
4	Temozolomide (Temodar)FDA LinkGeneric 02/2013 - 01/2006
4	VaccinesIBA 10/2010 - 09/2003
3	CytokinesIBA 09/2019 - 08/2003
3	Interleukin-2 (IL2)IBA 09/2019 - 08/2003
3	dabrafenibIBA 01/2014 - 11/2012
3	Pharmaceutical PreparationsIBA 01/2014 - 12/2007
3	InterferonsIBA 09/2013 - 09/2005
3	Biomarkers (Surrogate Marker)IBA 09/2011 - 02/2009
3	Interferon-alpha (Interferon Alfa)IBA 03/2011 - 09/2005
3	Peptides (Polypeptides)IBA 10/2010 - 04/2006
3	Carboplatin (JM8)FDA LinkGeneric 06/2009 - 10/2003
2	Fibronectins (Fibronectin)IBA 09/2019 - 01/2006
2	sonidegibIBA 07/2016 - 06/2015
2	Interferon alpha-2 (Roferon-A)FDA Link 12/2015 - 08/2009
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2014 - 03/2006
2	tremelimumabIBA 01/2014 - 02/2013
2	Sorafenib (BAY 43-9006)FDA Link 09/2013 - 06/2009
2	Cisplatin (Platino)FDA LinkGeneric 12/2011 - 01/2007
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 09/2011 - 10/2006
2	Biological ProductsIBA 03/2011 - 12/2007
2	Retinoblastoma ProteinIBA 02/2010 - 06/2006
2	ProMune (CpG 7909)IBA 09/2009 - 06/2008
2	Paclitaxel (Taxol)FDA LinkGeneric 06/2009 - 10/2003
2	Messenger RNA (mRNA)IBA 05/2008 - 06/2006
2	Immune Sera (Antisera)IBA 06/2006 - 05/2005
2	Phosphotransferases (Kinase)IBA 05/2006 - 08/2004
2	Monophenol Monooxygenase (Tyrosinase)IBA 04/2006 - 10/2005
1	Immune Checkpoint InhibitorsIBA 09/2019
1	Adenosine Triphosphate (ATP)IBA 09/2017
1	L-779,450IBA 02/2014
1	VemurafenibIBA 01/2014
1	Viscum ribosome inactivating proteinIBA 01/2014
1	Formaldehyde (Formol)FDA Link 01/2014
1	raf KinasesIBA 01/2014
1	CTLA-4 AntigenIBA 01/2014
1	Cell-Free Nucleic AcidsIBA 09/2013
1	AutoantibodiesIBA 03/2013
1	gamma-Aminobutyric Acid (GABA)IBA 03/2013
1	IpilimumabIBA 01/2013
1	Lipase (Acid Lipase)FDA Link 11/2012
1	Amylases FDA Link 11/2012
1	trametinibIBA 07/2012
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 07/2012
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 07/2012
1	Vindesine (Vindesin)IBA 12/2011
1	EnzymesIBA 09/2011
1	ImmunosorbentsIBA 09/2011
1	Toll-Like Receptor 9IBA 10/2010
1	MART-1 AntigenIBA 10/2010
1	HLA-A2 Antigen (HLA A2 Antigen)IBA 10/2010
1	ThymalfasinIBA 04/2010
1	HLA Antigens (Human Leukocyte Antigens)IBA 03/2010
1	Arginine (L-Arginine)FDA Link 03/2010
1	GTP-Binding Proteins (G-Protein)IBA 03/2010
1	Lenalidomide (CC 5013)FDA Link 01/2010
1	OligodeoxyribonucleotidesIBA 09/2009
1	Phosphopyruvate Hydratase (Enolase)IBA 01/2009
1	Galectin 3 (LGALS3)IBA 01/2009
1	ProteomeIBA 01/2009
1	CarbamatesIBA 08/2008
1	Histone Deacetylase InhibitorsIBA 08/2008

Therapy/Procedure

24	Therapeutics 09/2017 - 08/2003
10	Drug Therapy (Chemotherapy) 09/2017 - 10/2006
4	Immunotherapy 05/2008 - 09/2003
3	Lymph Node Excision (Lymph Node Dissection) 08/2013 - 03/2007
2	Combination Drug Therapy (Combination Chemotherapy) 09/2017 - 12/2011
2	Radiotherapy 01/2007 - 01/2006
1	Drug Tapering 07/2012
1	Cytoreduction Surgical Procedures 05/2012